Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.

Chen M, Sun F, Han L, Qu Z.

Oncotarget. 2016 May 31;7(22):33363-73. doi: 10.18632/oncotarget.9221.

2.

Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.

Zhao L, Yu C, Zhou S, Lau WB, Lau B, Luo Z, Lin Q, Yang H, Xuan Y, Yi T, Zhao X, Wei Y.

Oncotarget. 2016 Jan 12;7(2):1408-20. doi: 10.18632/oncotarget.6368.

3.

NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.

Sun F, Qu Z, Xiao Y, Zhou J, Burns TF, Stabile LP, Siegfried JM, Xiao G.

Oncogene. 2016 May 5;35(18):2299-310. doi: 10.1038/onc.2015.299.

4.

IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy Resistance.

Cox OT, O'Shea S, Tresse E, Bustamante-Garrido M, Kiran-Deevi R, O'Connor R.

Front Endocrinol (Lausanne). 2015 Jul 3;6:106. doi: 10.3389/fendo.2015.00106. Review.

6.

Differential roles of STAT3 in the initiation and growth of lung cancer.

Zhou J, Qu Z, Yan S, Sun F, Whitsett JA, Shapiro SD, Xiao G.

Oncogene. 2015 Jul;34(29):3804-14. doi: 10.1038/onc.2014.318.

7.

A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.

Liu S, Sun X, Wang M, Hou Y, Zhan Y, Jiang Y, Liu Z, Cao X, Chen P, Liu Z, Chen X, Tao Y, Xu C, Mao J, Cheng C, Li C, Hu Y, Wang L, Chin YE, Shi Y, Siebenlist U, Zhang X.

Gastroenterology. 2014 Oct;147(4):847-859.e11. doi: 10.1053/j.gastro.2014.06.006.

8.
9.

Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture.

Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, Cantrell MA, Rack PG, Neal JT, Chan CW, Yeung T, Gong X, Yuan J, Wilhelmy J, Robine S, Attardi LD, Plevritis SK, Hung KE, Chen CZ, Ji HP, Kuo CJ.

Nat Med. 2014 Jul;20(7):769-77. doi: 10.1038/nm.3585.

10.

PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.

Bowe RA, Cox OT, Ayllón V, Tresse E, Healy NC, Edmunds SJ, Huigsloot M, O'Connor R.

Mol Biol Cell. 2014 Jan;25(1):184-95. doi: 10.1091/mbc.E13-06-0306.

11.

PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.

Qu Z, Fu J, Ma H, Zhou J, Jin M, Mapara MY, Grusby MJ, Xiao G.

Cell Biosci. 2012 Jun 25;2(1):23. doi: 10.1186/2045-3701-2-23.

12.

Prioritization of SNPs for genome-wide association studies using an interaction model of genetic variation, gene expression, and trait variation.

Paik H, Kim J, Lee S, Heo HS, Hur CG, Lee D.

Mol Cells. 2012 Apr;33(4):351-61. doi: 10.1007/s10059-012-2264-7.

13.

Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon.

Rawłuszko AA, Horbacka K, Krokowicz P, Jagodziński PP.

BMC Cancer. 2011 Dec 19;11:522. doi: 10.1186/1471-2407-11-522.

14.

NF-κB and cancer: a paradigm of Yin-Yang.

Xiao G, Fu J.

Am J Cancer Res. 2011;1(2):192-221.

15.

Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.

Qu Z, Xiao G.

Viruses. 2011 Jun;3(6):714-49. doi: 10.3390/v3060714. Review.

16.
17.

The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis.

Fu J, Qu Z, Yan P, Ishikawa C, Aqeilan RI, Rabson AB, Xiao G.

Blood. 2011 Feb 3;117(5):1652-61. doi: 10.1182/blood-2010-08-303073.

18.

Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.

Fu J, Yan P, Li S, Qu Z, Xiao G.

Oncogene. 2010 Dec 9;29(49):6499-507. doi: 10.1038/onc.2010.374.

19.

Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.

Qu Z, Fu J, Yan P, Hu J, Cheng SY, Xiao G.

J Biol Chem. 2010 Apr 16;285(16):11786-92. doi: 10.1074/jbc.M109.086561.

Items per page

Supplemental Content

Support Center